Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Mar 25 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 2.19 | 48,393 | 105.98 k | 48,393 |
10 Feb 25 | SION Sionna Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 18 | 60,000 | 1.08 mm | 807,727 |
10 Feb 25 | SION Sionna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 747,727 | 0.00 | 747,727 |
10 Feb 25 | SION Sionna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,886,293 | 0.00 | 2,886,293 |
10 Feb 25 | SION Sionna Therapeutics | Series C convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 1,092,504 | 0.00 | 0 |
10 Feb 25 | SION Sionna Therapeutics | Series C convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 61,463 | 0.00 | 0 |
10 Feb 25 | SION Sionna Therapeutics | Series B convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 1,298,332 | 0.00 | 0 |
10 Feb 25 | SION Sionna Therapeutics | Series A convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 1,806,317 | 0.00 | 0 |
10 Feb 25 | SION Sionna Therapeutics | Series Seed convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 1,051,051 | 0.00 | 0 |
9 Jul 24 | KYMR Kymera Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 39.26 | 20,238 | 794.54 k | 723,246 |